Actual Medicinal Product (AMP) Exelon 4.6mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd)

Stability Information

Stability
not_set logo We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
Notes
There are no stability notes available for this medicine.
Generic
Rivastigmine
Formulation
Rivastigmine 4.6mg/24hours transdermal patches
  • Rivastigmine
    • Rivastigmine 4.6mg/24hours transdermal patches
      • Exelon 4.6mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd)

Alternative Suppliers (20)